Roche to invest $50 billion in the U.S. as pharma tariff threat lingers

From Campari to Louis Vuitton: The companies bowing to Trump and strengthening their US presence

The tariff war launched by U.S. President Donald Trump against the rest of the world has had numerous negative consequences for the world’s largest economy: widespread declines on Wall Street, a worrying deterioration in the U.S. debt market, a weakened dollar, a downgraded growth forecast by the IMF for this year, and retaliatory tariffs imposed by other countries. Seguir leyendo

Roche, answering tariff threat, pledges $50B to US drug production

The pharmaceutical company joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing facilities in the U.S.

Large pharmaceutical groups have begun to relocate their production to the United States, the world's leading drug market.

Mainstream Media Won't Tell You About the New Drug Factories

Do you know who our major trading partners are? The answer is Switzerland at number one, and Mexico at number two. Switzerland is the home of La Roche Pharmaceuticals. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. They plan to build more of their […] The post Mainstream Media Won’t Tell You About the New Drug Factories appeared first on www.independentsentinel.co…

Domestic and international companies like Apple, Nvidia, Hyundai, among others, will invest billions of dollars in factories and jobs in the US.

Roche Announces $50B US Investment Plan to Avoid Tariffs

Swiss pharmaceutical giant Roche has announced a $50 billion US investment plan as the industry is facing potential tariffs